XANAX XR® 3 mg tablets, single dose

DRUG2 trials

Sponsors

Actavis Inc.

Conditions

Healthy

Phase 1

A Relative Bioavailability Study of Alprazolam 3 mg ER Tablets Under Fasting Conditions

CompletedNCT00865761

Actavis Inc.Healthy

Start: 2005-09-30End: 2005-09-30Updated: 2010-08-17

A Relative Bioavailability Study of Alprazolam 3 mg Extended Release Tablets Under Non-fasting Conditions

CompletedNCT00865657

Actavis Inc.Healthy

Start: 2005-09-30End: 2005-09-30Updated: 2010-08-17